AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimlist M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Rech Elist Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimlist M 2mg/500mg Tablet SR

DiabetaComb 2mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. DiabetaComb should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle adjustments significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect. Learn to recognize symptoms – sweating, dizziness, headache, trembling – and know how to treat them. Maintain regular eating habits and always carry a rapid-acting glucose source, such as sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. DiabetaComb is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Consult your doctor before using this medication if you are pregnant or breastfeeding. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Primary Ingredients of Glimlist M 2mg/500mg Tablet SR

No text provided to rephrase.

Uses of Glimlist M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimlist M 2mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; do not crush, chew, or divide it. Glimlist M 2mg/500mg Sustained-Release tablets should be taken with a meal.

Common Side effects of Glimlist M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimlist M 2mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glimlist M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume this medication with food.

How Glimlist M 2mg/500mg Tablet SR works:

Glimlist M SR tablets (2mg/500mg) combine glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimlist M 2mg/500mg SR tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimlist M 2mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimlist M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimlist M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is necessary. This medication is contraindicated for individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimlist M 2mg/500mg SR tablets cautiously. Dosage modification of Glimlist M 2mg/500mg SR tablets may be necessary. Medical advice is recommended. For those with mild to moderate liver disease, Glimlist M 2mg/500mg SR tablets are typically initiated at a low dosage; however, its use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Glimlist M 2mg/500mg Tablet SR :

Should you forget a Glimlist M 2mg/500mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimlist M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimlist M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimlist M 2mg/500mg Tablet SR can cause lactic acidosis (MALA), a serious medical emergency resulting from excess blood lactic acid. This rare but harmful side effect is more likely in patients with kidney disease, older individuals, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimlist M and seek immediate medical attention.
Glimlist M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimlist M 2mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimlist M 2mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Glimlist M 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimlist M 2mg/500mg Tablet SR and alcohol is unsafe. Alcohol can lower blood sugar, risking hypoglycemia, and increase the risk of lactic acidosis.
Glimlist M 2mg/500mg Tabl...
57
MRP 69
17% off